pharmaceutical company in Vancouver

Developing breakthrough complement-targeted therapeutics.

DelMar Pharma (NASDAQ:DMPI) develops cancer therapies in new indications where patients fail/unlikely to respond to modern therapy. Clinical trial in GBM

Microdermics provides pharmaceutical companies with precise and easy access to the skin for breakthrough applications in drug delivery and diagnostics. Our intradermal platform can be customi…

Anritsu, as a cutting-edge company in the ICT services industry, is operating its test and measurement business globally to support the building of the next generation of networks. Providing qual…

Concord has prepared over 650+ business plans in industry sectors globally that have raised over $1.3 Billion in venture capital and investment.